The world’s medical research community is reeling tonight after a cache of documents, obtained exclusively by this newsroom, reveals that a private biobank in Tasmania has been trading in human tissue without proper consent. Sources confirm that over 2,000 samples were taken from deceased individuals between 2015 and 2020, with organs and other tissues sold to pharmaceutical companies for drug trials. The Tasmania Tissue Repository, which operated out of a nondescript warehouse in Hobart, allegedly paid funeral homes cash to extract material before cremation. Families were never told.
The British government has now stepped in. In a statement released by the Department of Health this morning, a spokesperson said: “This is an abhorrent breach of trust. Britain cannot stand by while the dead are exploited for profit. We call on the international community to adopt binding global ethical standards for medical research.” The call comes as the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) launches its own investigation into whether any British firms received these tainted samples.
I have spent the last two weeks in Tasmania, tracking the paper trail. It is a grim business. The documents show that the Repository’s chief executive, Dr. Helena Vance, a former pathologist struck off in Australia for misconduct, oversaw the operation. In internal emails, she boasted of “solving the shortage of viable human tissue for cutting-edge research.” The shortage is real: demand for fresh tissue has skyrocketed as personalised medicine expands. But the solution, it appears, was to harvest without consent.
Funeral home owners were paid a finder’s fee of up to $500 per body. One source, a former employee who asked to remain anonymous, told me: “They said the families would never know. The bodies were going to be ashes anyway. It was free money.” But the families were never asked. The consent forms, found buried in a filing cabinet, were forged with signatures traced from obituaries.
The scandal has already claimed victims. Margaret Chen, 72, of Launceston, buried her husband in 2017. She only learned his tissue was sold when I knocked on her door. “I want his body back,” she said, her voice trembling. “But they tell me it’s been used up in some experiment.” An oncology department at a prestigious London hospital has already admitted receiving samples, though they claim they were “misled” about the provenance.
The implications are vast. Hundreds of research studies, some published in leading journals, may have used this stolen tissue. The MHRA is now re-examining trials that relied on Tasmanian tissue, which could delay drug approvals and potentially invalidate years of work.
The British call for global ethical standards has been met with cautious praise from groups like the World Medical Association. But critics argue that without enforcement, it is just theatre. I have seen this play before. After the Alder Hey scandal in 1999, where organs were retained without consent, the UK tightened its laws. But this trade is global, and borders mean nothing to graft.
Tonight, Dr. Vance is believed to be in a Sydney hotel, her passport seized. The Tasmanian police have not yet charged her, but sources say charges of fraud and theft are imminent. Meanwhile, the funeral homes involved have shuttered their doors. The families, though, still have no answers. And the body count keeps rising.
